Evidence map›Paper›PMID 30522011›Full record

ArticleColloids and surfaces. B, Biointerfaces2019

Evaluation of hetero-multivalent lectin binding using a turbidity-based emulsion agglutination assay.

Nolan C Worstell, Akshi Singla, Hung-Jen Wu

Abstract readEvaluation Study
In one paragraph

Article in Colloids and surfaces. B, Biointerfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Hetero-Multivalent Targeted Liposomal Drug Delivery to TreatACS applied materials & interfaces · 2022
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nolan C WorstellDept. of Chemical Engineering, Texas A&M University, College Station, TX, 77843, USA.
Akshi SinglaDept. of Chemical Engineering, Texas A&M University, College Station, TX, 77843, USA.
Hung-Jen WuDept. of Chemical Engineering, Texas A&M University, College Station, TX, 77843, USA. Electronic address: hjwu@tamu.edu.

Funding

Microvesicle Isolation from Mycobacterium tuberculosis infected macrophage usingR03AI113585 · NIAID · TEXAS ENGINEERING EXPERIMENT STATION · PI UGAZ, VICTOR M, WU, HUNG-JEN · 2014 to 2015
$137k
NIAID NIH HHS R03 AI113585
6 · The paper itself

Abstract

Lectin hetero-multivalency, binding to two or more different types of ligands, has been demonstrated to play a role in case of both LecA (a Pseudomonas aeruginosa adhesin) and Cholera Toxin subunit B (a Vibrio cholerae toxin). In order to screen the ligand candidates that involve in hetero-multivalent binding from large molecular libraries, we present a turbidity-based emulsion agglutination (TEA) assay that can be conducted in a high-throughput format using the standard laboratory instruments and reagents. The benefit of this assay is that it relies on the use of emulsions that can be formed using ultrasonication, minimizing the bottleneck of substrate surface functionalization. By measuring the change in turbidity, we could quantify the lectin-induced aggregation rate of oil droplets to determine the relative binding strength between different ligand combinations. The TEA results are consistent with our prior binding results using a nanocube sensor. The developed TEA assay can serve as a high-throughput and customizable tool to screen the potential ligands involved in hetero-multivalent binding.

Indexed as

AlgorithmsBacterial AdhesionBinding SitesCholera ToxinEmulsionsKineticsLatex Fixation TestsLectinsNephelometry and TurbidimetryProtein BindingPseudomonas aeruginosaReproducibility of ResultsCholera ToxinEmulsionsLectinsAgglutinationEmulsionGlycolipidHetero-multivalencyLectinTurbidity

Identifiers

PMID30522011
PMCPMC10079213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.